Back to Search
Start Over
Alnylam, Cubist report progress on R&D effort
- Source :
- Chain Drug Review. August 3, 2009, Vol. 31 Issue 13, p47, 1 p.
- Publication Year :
- 2009
-
Abstract
- CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals Inc. and Cubist Pharmaceuticals Inc. confirm that a midstage study of their experimental drug for a respiratory infection has met its major objective. The biopharmaceutical [...]
- Subjects :
- Alnylam Pharmaceuticals Inc. -- Research
Cubist Pharmaceuticals Inc. -- Research
Pharmaceutical industry -- Research
Inhaled medication -- Usage
Inhaled medication -- Research
Respiratory syncytial virus -- Drug therapy
Respiratory syncytial virus -- Research
Respiratory tract infections -- Research
Respiratory tract infections -- Drug therapy
Business
Pharmaceuticals and cosmetics industries
Retail industry
Subjects
Details
- Language :
- English
- ISSN :
- 01649914
- Volume :
- 31
- Issue :
- 13
- Database :
- Gale General OneFile
- Journal :
- Chain Drug Review
- Publication Type :
- Periodical
- Accession number :
- edsgcl.205907164